Sympathetic nerve activity in women 40 years after a hypertensive pregnancy

Journal of Hypertension

Volumn 30, Issue 6, 2012, Pages 1203-1210

  Collén, Anna Clara ^a   Manhem, Karin ^a   Sverrisdóttir, Yrsa Bergmann ^b  

^a Department of Emergency and Cardiovascular Medicine   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

follow up studies; hypertension; pregnancy; sympathetic nervous system; women

Indexed keywords

ADRENERGIC SYSTEM; ADULT; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; LABORATORY TEST; NERVE CONDUCTION; PREGNANCY DISORDER; PRIORITY JOURNAL; PULSE WAVE; STROOP TEST; SYMPATHETIC NERVE; SYSTOLIC BLOOD PRESSURE;

EID: 84861052327     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283531ed2     Document Type: Article

References (49)

1. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, Smith WC. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003; 326:845-849.
2. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009; 53:944-951.
3. Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA 2005; 294:2751-2757.
4. Marín R, Gorostidi M, Portal C, Sánchez M, Sánchez E, Alvarez J. Longterm prognosis of hypertension in pregnancy. Hypertension Pregnancy 2000; 19:199-209.
5. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after preeclampsia: population based cohort study. BMJ 2001; 323:1213-1217.
6. Craici I, Wagner S, Garovic VD. Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test? Ther Adv Cardiovasc Dis 2008; 2:249-259.
7. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Preeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007; 335:974-986.
8. Kaaja R. Insulin resistance syndrome in preeclampsia. Semin Reprod Endocrinol 1998; 16:41-46.
9. Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 2008; 51:527-539.
10. Safar ME, Czernichow S, Blacher J. Obesity, arterial stiffness, and cardiovascular risk. J Am Soc Nephrol 2006; 17 (4 Suppl 2):S109-S111.
11. Wang X, Keith JC Jr., Struthers AD, Feuerstein GZ. Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk. Cardiovasc Ther 2008; 26:214-223.
12. Chidac Y, Steptoe A. Greater cardiovascular responses to laboratory mental stress are associated with poor subsequent cardiovascular risk status: a meta-analysis of prospective evidence. Hypertension 2010; 55:1026-1032.
13. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 2009; 54:690-697.
14. Brook RD, Julius S. Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens 2000; 13 (6 Suppl 2):S112-S122.
15. Greenwood JP, Scott EM, Stoker JB, Walker JJ, Mary DA. Sympathetic neural mechanisms in normal and hypertensive pregnancy in humans. Circulation 2001; 104:2200-2204.
16. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Preeclampsia: a state of sympathetic overactivity. N Engl J Med 1996; 335:1480-1485.
17. Svensson A. Hypertension in pregnancy. Clin Exp Hypertens 1993; 15:1353-1361.
18. Svensson A. Hypertension in pregnancy. Department of Medicine, Ö stra Hospital, 1985, University of Göteborg: Göteborg.
19. Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 1979; 59:919-957.
20. Sverrisdottir YB, Rundqvist B, Johannsson G, Elam M. Sympathetic neural burst amplitude distribution: a more specific indicator of sympathoexcitation in human heart failure. Circulation 2000; 102:2076-2081.
21. Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension 1989; 13:647-655.
22. Kienbaum P, Karlssonn T, Sverrisdottir YB, Elam M, Wallin BG. Two sites for modulation of human sympathetic activity by arterial baroreceptorš J Physiol 2001; 531:861-869.
23. Wallin BG, Esler M, Dorward P, Eisenhofer G, Ferrier C, Westerman R, Jennings G. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol 1992; 453:45-58.
24. Wallin BG, Thompson JM, Jennings GL, Esler MD. Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol 1996; 491:881-887.
25. Wallin BG, Charkoudian N. Sympathetic neural control of integrated cardiovascular function: insights from measurement of human sympathetic nerve activity. Muscle Nerve 2007; 36:595-614.
26. Fagius J, Wallin BG. Long-term variability and reproducibility of resting human muscle nerve sympathetic activity at rest, as reassessed after a decade. Clin Auton Res 1993; 3:201-205.
27. Steptoe A, Vogele C. Methodology of mental stress testing in cardiovascular research. Circulation 1991; 83 (4 Suppl):II14-24.
28. Seibt R, Boucsein W, Scheuch K. Effects of different stress settings on cardiovascular parameters and their relationship to daily life blood pressure in normotensives, borderline hypertensives and hypertensives. Ergonomics 1998; 41:634-648.
29. Matsukawa T, Gotoh E, Uneda S, Miyajima E, Shionoiri H, Tochikubo O, Ishii M. Augmented sympathetic nerve activity in response to stressors in young borderline hypertensive men. Acta Physiol Scand 1991; 141:157-165.
30. Strauss GP, Allen DN, Jorgensen ML, Cramer SL. Test-retest reliability of standard and emotional stroop tasks: an investigation of color-word and picture-word versions. Assessment 2005; 12:330-337.
31. Jern S, Pilhall M, Jern C, Carlsson SG. Short-term reproducibility of a mental arithmetic stress test. Clin Sci 1991; 81:593-601.
32. Callister R, Suwarno NO, Seals DR. Sympathetic activity is influenced by task difficulty and stress perception during mental challenge in humans. J Physiol 1992; 454:373-387.
33. Middlekauff HR, Nguyen AH, Negrao CE, Nitzsche EU, Hoh CK, Natterson BA, et al. Impact of acute mental stress on sympathetic nerve activity and regional blood flow in advanced heart failure: implications for 'triggering' adverse cardiac events. Circulation 1997; 96:1835-1842.
34. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, Webb DJ. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998; 16:2079-2084.
35. Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Arenare F, Spaziani D, Mancia G. Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction. Hypertension 2009; 53:205-209.
36. Charkoudian N, Rabbitts JA. Sympathetic neural mechanisms in human cardiovascular health and disease. Mayo Clin Proc 2009; 84:822-830.
37. Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 2003; 108:560-565.
38. Andersson OK, Almgren T, Persson B, Samuelsson O, Hedner T, Wilhelmsen L. Survival in treated hypertension: follow up study after two decades. BMJ 1998; 317:167-171.
39. Bog-Hansen E, Lindblad U, Bengtsson K, Ranstam J, Melander A, Rastam L. Risk factor clustering in patients with hypertension and noninsulin-dependent diabetes mellitus. The Skaraborg Hypertension Project. J Intern Med 1998; 243:223-232.
40. Ridderstrale M, Gudbjornsdottir S, Eliasson B, Nilsson PM, Cederholm J. Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register. J Intern Med 2006; 259:314-322.
41. Nilsson PM, Gudbjornsdottir S, Eliasson B, Cederholm J. Hypertension in diabetes: trends in clinical control in repeated large-scale national surveys from Sweden. J Hum Hypertens 2003; 17:37-44.
42. Silander K, Alanne M, Kristiansson K, Saarela O, Ripatti S, Auro K, et al. Gender differences in genetic risk profiles for cardiovascular disease. PloS ONE 2008; 3:e3615.
43. Kiechl S, Willeit J, Bonora E, Schwarz S, Xu Q. No association between dehydroepiandrosterone sulfate and development of atherosclerosis in a prospective population study (Bruneck Study). Arterioscler Thromb Vasc Biol 2000; 20:1094-1100.
44. Ohlsson C, Labrie F, Barrett-Connor E, Karlsson MK, Ljunggren O, Vandenput L, et al. Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men. J Clin Endocrinol Metab 2010; 95:4406-4414.
45. Fagius J, Westermark K, Karlsson A. Baroreflex-governed sympathetic outflow to muscle vasculature is increased in hypothyroidism. Clin Endocrinol (Oxf) 1990; 33:177-185.
46. Matsukawa T, Mano T, Gotoh E, Minamisawa K, Ishii M. Altered muscle sympathetic nerve activity in hyperthyroidism and hypothyroidism. J Auton Nerv Syst 1993; 42:171-175.
47. Sverrisdottir YB, Elam M, Herlitz H, Bengtsson BA, Johannsson G. Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency. J Clin Endocrinol Metab 1998; 83:1881-1885.
48. Sverrisdottir YB, Elam M, Caidahl K, Soderling AS, Herlitz H, Johannsson G. The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a doubleblind, placebo-controlled, crossover, short-term trial followed by long- term open GH replacement in hypopituitary adults. J Hypertens 2003; 21:1905-1914.
49. Sverrisdottir YB, Mogren T, Kataoka J, Janson PO, Stener-Victorin E. Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? Am J Physiol Endocrinol Metab 2008; 294:E576-E581.